$15.90
Price
$1.8B
Market Cap
—
P/E Ratio
-4.4
Forward P/E
$-4.25
EPS (TTM)
—
Dividend Yield
$511M
Cash
$210M
Total Debt
116M
Shares Out
$5.90
$28.25
52-Week Range
Institutional Ownership of INTELLIA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for INTELLIA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2023-Q2 | |||||
| SELL | EXIT | — | — | $40.98 | |
| 2023-Q1 | |||||
| SELL | -22.4% | 1.6M | $58M | $39.02 | |
| 2022-Q4 | |||||
| BUY | +7.0% | 2.0M | $71M | $49.53 | |
| 2022-Q3 | |||||
| SELL | -15.2% | 1.9M | $106M | $63.18 | |
| 2022-Q2 | |||||
| BUY | +74.2% | 2.2M | $115M | $49.03 | |
| 2022-Q1 | |||||
| SELL | -19.0% | 1.3M | $172M | $85.80 | |
| 2021-Q4 | |||||
| BUY | +23.4% | 1.6M | $187M | $128.08 | |
| 2021-Q3 | |||||
| BUY | +31.2% | 1.3M | $172M | $152.73 | |
| 2021-Q2 | |||||
| BUY | NEW | 975.1K | $158M | $73.77 | |
Insider Trading for INTELLIA THERAPEUTICS INC
6 Months Insider Sentiment
Buy $1.4M
Sell $1.6M
1
Buys
12
Sells
-239K
Net
0
Grants
Largest
$1.4M
Cohen
$474K
Leonard
$341K
Leonard
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 05, 2026 | Birgit C Schultes | EVP, Chief Scientific Officer | SELL | 8.5K | $9.21 | $78K |
| Jan 05, 2026 | Edward J Dulac III | EVP, Chief Financial Officer | SELL | 6.4K | $9.21 | $59K |
| Jan 05, 2026 | David Lebwohl | EVP, Chief Medical Officer | SELL | 11.9K | $9.21 | $110K |
| Jan 05, 2026 | John M Leonard | President and CEO | SELL | 34.1K | $9.21 | $314K |
| Jan 05, 2026 | Eliana Clark | EVP, Chief Technical Officer | SELL | 9.5K | $9.21 | $88K |
| Jan 05, 2026 | Fred E Cohen | Director | BUY | 150.0K | $9.35 | $1.4M |
| Jan 05, 2026 | James Basta | EVP, General Counsel | SELL | 10.4K | $9.21 | $96K |
| Jan 05, 2026 | Michael P Dube | VP, Chief Accounting Officer | SELL | 3.0K | $9.21 | $28K |
| Dec 12, 2025 | John M Leonard | President and CEO | EXERCISE | 8.6K | $6.83 | $58K |
| Dec 11, 2025 | John M Leonard | President and CEO | EXERCISE | 50.0K | $6.83 | $341K |
| Dec 11, 2025 | John M Leonard | President and CEO | SELL | 5.4K | $9.59 | $51K |
| Dec 11, 2025 | John M Leonard | President and CEO | SELL | 32.8K | $9.47 | $311K |
| Dec 11, 2025 | John M Leonard | President and CEO | SELL | 50.0K | $9.49 | $474K |
| Oct 01, 2025 | Michael P Dube | VP, Chief Accounting Officer | SELL | 1.9K | $17.38 | $33K |
| Oct 01, 2025 | Birgit C Schultes | EVP, Chief Scientific Officer | SELL | 31 | $17.38 | $539 |